Rizk M, Zou L, Savic R, Dooley K. Importance of drug pharmacokinetics at the site of action. Clin Transl Sci. 2017;10(3):133–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Illamola SM, Hirt D, Tréluyer JM, Urien S, Benaboud S. Challenges regarding analysis of unbound fraction of highly bound protein antiretroviral drugs in several biological matrices: lack of harmonisation and guidelines. Drug Discov Today. 2015;20(4):466–74.

Article  CAS  PubMed  Google Scholar 

Gonzalez D, Schmidt S, Derendorf H. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin Microbiol Rev. 2013;26(2):274–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fritz S, Chaitow L, Hymel GM. CHAPTER 15 - Medical Treatment for Illness and Injury. In: Fritz S, Chaitow L, Hymel GM, editors. Clinical Massage in the Healthcare Setting [Internet]. Saint Louis: Mosby; 2008 [Accessed 2025 Apr 1]. p. 514-33.

Onetto AJ, Sharif S. Drug Distribution. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [Accessed 2025 Apr 1]. http://www.ncbi.nlm.nih.gov/books/NBK567736/.

Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sörgel F. Penetration of antibacterials into bone. Clin Pharmacokinet. 2009;48(2):89–124.

Article  CAS  PubMed  Google Scholar 

Wautier JL, Wautier MP. Vascular permeability in diseases. Int J Mol Sci. 2022;23(7):3645.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morales Castro D, Dresser L, Granton J, Fan E. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023;62(2):209–20.

Article  PubMed  PubMed Central  Google Scholar 

Gandia P, Decheiver S, Picard M, Guilhaumou R, Baklouti S, Concordet D. Hypoalbuminemia and pharmacokinetics: when the misunderstanding of a fundamental concept leads to repeated errors over decades. Antibiotics. 2023;12(3):515.

Article  PubMed  PubMed Central  Google Scholar 

Hammarlund-Udenaes M. Microdialysis as an important technique in systems pharmacology—a historical and methodological review. AAPS J. 2017;19(5):1294–303.

Article  CAS  PubMed  Google Scholar 

Jordan G, Staack RF. Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards? Bioanalysis. 2023;15(1):5–16.

Article  CAS  PubMed  Google Scholar 

Boelig RC, Lam E, Rochani A, Kaushal G, Roman A, Kraft WK. Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one-time oral dosing in pregnancy. Clin Transl Sci. 2021;14(6):2431–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park H, Kim E, Moon B, Lim N, Lee B, Kim S. In vivo tissue pharmacokinetics of carbon-11-labeled clozapine in healthy volunteers: a positron emission tomography study. CPT Pharmacometr Syst Pharmacol. 2015;4(5):305–11.

Article  CAS  Google Scholar 

Verscheijden LFM, Koenderink JB, de Wildt SN, Russel FGM. Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis. PLOS Comput Biol. 2019;15(6):e1007117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Gaag S, Jordens T, Yaqub M, Grijseels R, van Valkengoed DW, de Langen EN, et al. Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification. CPT Pharmacomet Syst Pharmacol [Internet]. 2025. https://doi.org/10.1002/psp4.70006.

Article  Google Scholar 

Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development—part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacometr Syst Pharmacol. 2013;2(4):e38.

Article  CAS  Google Scholar 

Minichmayr IK, Dreesen E, Centanni M, Wang Z, Hoffert Y, Friberg LE, et al. Model-informed precision dosing: State of the art and future perspectives. Adv Drug Deliv Rev. 2024;1(215):115421.

Article  Google Scholar 

Wicha SG, Märtson AG, Nielsen EI, Koch BCP, Friberg LE, Alffenaar JW, et al. From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clin Pharmacol Ther. 2021;109(4):928–41.

Article  CAS  PubMed  Google Scholar 

Riegelman S, Loo JCK, Rowland M. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci. 1968;57(1):117–23.

Article  CAS  PubMed  Google Scholar 

Nestorov IA, Aarons LJ, Arundel PA, Rowland M. Lumping of whole-body physiologically based pharmacokinetic models. J Pharmacokinet Biopharm. 1998;26(1):21–46.

Article  CAS  PubMed  Google Scholar 

Cao Y, Jusko WJ. Applications of minimal physiologically-based pharmacokinetic models. J Pharmacokinet Pharmacodyn. 2012;39(6):711–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krzyzanski W, Milad MA, Jobe AH, Jusko WJ. Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: application to antenatal corticosteroids. CPT Pharmacometr Syst Pharmacol. 2023;12(5):668–80.

Article  CAS  Google Scholar 

Al Hroot J, Reeder J, Yuan X, Gu K, Walter EB, Boole L, et al. Determining an appropriate fosfomycin (ZTI-01) dosing regimen in pneumonia patients by utilizing minimal PBPK modeling and target attainment analysis. Antimicrob Agents Chemother. 2025;69(6):e01869-e1924.

Article  PubMed  PubMed Central  Google Scholar 

Parmar KR, Lukka PB, Wagh S, Temrikar ZH, Liu J, Lee RE, et al. Development of a minimalistic physiologically based pharmacokinetic (mPBPK) model for the preclinical development of spectinamide antibiotics. Pharmaceutics. 2023;15(6):1759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puszkiel A, Bousquet G, Stanke-Labesque F, Stocco J, Decq P, Chevillard L, et al. A minimal PBPK model for plasma and cerebrospinal fluid pharmacokinetics of trastuzumab after intracerebroventricular administration in patients with HER2-positive brain metastatic localizations. Pharm Res. 2023;40(11):2687–97.

Article  CAS  PubMed  Google Scholar 

Michelet R, Petersson K, Huisman MC, Menke‐van der Houven van Oordt CW, Miedema IHC, Thiele A, et al. A minimal physiologically‐based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti‐LAG‐3 monoclonal antibody. CPT Pharmacometr Syst Pharmacol. 2024;14(3):460–73.

Levy G. Pharmacologic target-mediated drug disposition. Clin Pharmacol Ther. 1994;56(3):248–52.

Article  CAS  PubMed  Google Scholar 

Cao Y, Jusko WJ. Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies. J Pharmacokinet Pharmacodyn. 2014;41(4):375–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu M, Sun D, An G. Exploring the impact of pharmacological target-mediated low plasma exposure in lead compound selection in drug discovery—a modeling approach. AAPS J. 2024;26(6):112.

Article  CAS  PubMed  Google Scholar 

Ayyar VS, Lee JB, Wang W, Pryor M, Zhuang Y, Wilde T, Vermeulen A. Minimal physiologically-based pharmacokinetic (mPBPK) metamodeling of target engagement in skin informs anti-IL17A drug development in psoriasis. Front Pharmacol. 2022;13:862291. https://doi.org/10.3389/fphar.2022.862291/full.

Article  PubMed  PubMed Central  Google Scholar 

Li X, Jusko WJ, Cao Y. Role of interstitial fluid turnover on target suppression by therapeutic biologics using a minimal physiologically based pharmacokinetic model. J Pharmacol Exp Ther. 2018;367(1):1–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patidar K, Pillai N, Dhakal S, Avery LB, Mavroudis PD. A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokinetics. J Pharmacokinet Pharmacodyn. 2024;51(5):477–92.

Article  CAS  PubMed  PubMed Central